Related Experiment Video
Updated: Jul 18, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Tumor antigen-based immunotherapy and immunoprevention of cancer
Sean O Ryan1, Kira R Gantt, Olivera J Finn
1Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Abstract:
Any approach to the treatment and prevention of cancer must face the daunting reality that each cancer may be as individual as the patient in whom it has evolved. The challenge is also to develop a therapy that would eradicate that which is abnormal while preserving what is normal. For many years, therapies have been sought that could target a specific abnormal cancerous processes, such as rapid division or increased vascular flow, but with only limited success. Unfortunately, these successes have also been accompanied by varying degrees of toxicity and there is currently no standard therapy that can eradicate clinical disease and prevent recurrence while leaving normal tissue unharmed. However, approaches directed towards manipulating tumor-specific immunity hold promise for effective treatment and lasting cure. These approaches are based on the exceptional specificity of the immune system, the potential for long-term protective memory, and the accumulated evidence that affected individuals have spontaneous immune responses against their own tumors.
Insights
Cancer treatment faces challenges due to tumor individuality and treatment toxicity. Manipulating tumor-specific immunity offers a promising approach for effective cancer eradication and lasting cure.
Area of Science:
- Oncology
- Immunology
- Cancer Therapy
Background:
- Cancer treatment faces the challenge of targeting abnormal cells while preserving normal tissue.
- Current therapies targeting rapid cell division or vascular flow have limited success and significant toxicity.
- No standard therapy effectively eradicates cancer and prevents recurrence without harming normal tissues.
Purpose of the Study:
- To explore the potential of tumor-specific immunity for cancer treatment and prevention.
- To leverage the immune system's specificity for targeted cancer eradication.
- To investigate approaches for achieving lasting cancer cure with minimal side effects.
Main Methods:
- Focus on immune system manipulation against tumors.
- Exploiting the natural immune response against cancer.
- Developing therapies based on tumor-specific immune recognition.
Main Results:
- Tumor-specific immunity holds promise for effective cancer treatment.
- Immune-based approaches offer potential for lasting cure.
- Spontaneous anti-tumor immune responses are observed in patients.
Conclusions:
- Manipulating tumor-specific immunity is a promising strategy for cancer therapy.
- The immune system's specificity and memory offer advantages for cancer treatment.
- Harnessing endogenous anti-tumor immunity could lead to durable cancer remission.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

